Literature DB >> 9100215

Phenylketonuria: current dietary treatment practices in the United States and Canada.

R O Fisch1, R Matalon, S Weisberg, K Michals.   

Abstract

OBJECTIVE: A survey of treatment centers for phenylketonuria (PKU) in the United States and Canada was undertaken regarding current practices of dietary treatment of PKU.
METHODS: A total of 111 centers, who follow more than 6,950 patients with PKU responded to the survey.
RESULTS: The majority of the centers, 87%, favor life-long dietary control of phenylalanine intake. The survey found lack of uniformity regarding acceptable range of blood phenylalanine levels. The frequency of clinic visits varied and became less frequent as patients got older. Although most of the clinics recommend diet for life, only one-third of the clinics follow patients beyond the age of 18 years, therefore, it is unclear who manages these patients beyond that age. The survey also showed a high number of families with children who were reported for medical neglect (3.0% compared to < 0.06% in the general population). Because of dietary noncompliance, 1% of the children were removed from the home. DISCUSSION: The survey points to the common treatment goal of diet for life for patients with PKU and underscores the need for uniform guidelines for achieving this goal.

Entities:  

Mesh:

Year:  1997        PMID: 9100215     DOI: 10.1080/07315724.1997.10718665

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  9 in total

1.  Living with phenylketonuria: perspectives of patients and their families.

Authors:  C Bilginsoy; N Waitzman; C O Leonard; S L Ernst
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Authors:  S Yannicelli; D M Medeiros
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

3.  Large neutral amino acids in the treatment of phenylketonuria (PKU).

Authors:  R Matalon; K Michals-Matalon; G Bhatia; E Grechanina; P Novikov; J D McDonald; J Grady; S K Tyring; F Guttler
Journal:  J Inherit Metab Dis       Date:  2006-09-21       Impact factor: 4.982

Review 4.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 5.  Dietary interventions for phenylketonuria.

Authors:  Vanessa J Poustie; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Dietary interventions for phenylketonuria.

Authors:  Elisabeth Jameson; Tracey Remmington
Journal:  Cochrane Database Syst Rev       Date:  2020-07-16

7.  Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine.

Authors:  R Matalon; K Michals-Matalon; G Bhatia; A B Burlina; A P Burlina; C Braga; L Fiori; M Giovannini; E Grechanina; P Novikov; J Grady; S K Tyring; F Guttler
Journal:  J Inherit Metab Dis       Date:  2007-02-27       Impact factor: 4.750

8.  Peak bone mass in patients with phenylketonuria.

Authors:  D Modan-Moses; I Vered; G Schwartz; Y Anikster; S Abraham; R Segev; Ori Efrati
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

9.  Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids.

Authors:  D Concolino; I Mascaro; M T Moricca; G Bonapace; K Matalon; J Trapasso; G Radhakrishnan; C Ferrara; R Matalon; P Strisciuglio
Journal:  Eur J Clin Nutr       Date:  2016-09-14       Impact factor: 4.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.